Specific inhibition of the Survivin-CRM1 interaction by peptide-modified molecular tweezers.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
08 03 2021
Historique:
received: 03 02 2020
accepted: 02 02 2021
entrez: 9 3 2021
pubmed: 10 3 2021
medline: 23 3 2021
Statut: epublish

Résumé

Survivin's dual function as apoptosis inhibitor and regulator of cell proliferation is mediated via its interaction with the export receptor CRM1. This protein-protein interaction represents an attractive target in cancer research and therapy. Here, we report a sophisticated strategy addressing Survivin's nuclear export signal (NES), the binding site of CRM1, with advanced supramolecular tweezers for lysine and arginine. These were covalently connected to small peptides resembling the natural, self-complementary dimer interface which largely overlaps with the NES. Several biochemical methods demonstrated sequence-selective NES recognition and interference with the critical receptor interaction. These data were strongly supported by molecular dynamics simulations and multiscale computational studies. Rational design of lysine tweezers equipped with a peptidic recognition element thus allowed to address a previously unapproachable protein surface area. As an experimental proof-of-principle for specific transport signal interference, this concept should be transferable to any protein epitope with a flanking well-accessible lysine.

Identifiants

pubmed: 33686072
doi: 10.1038/s41467-021-21753-9
pii: 10.1038/s41467-021-21753-9
pmc: PMC7940618
doi:

Substances chimiques

BIRC5 protein, human 0
Inhibitor of Apoptosis Proteins 0
Karyopherins 0
Nuclear Export Signals 0
Receptors, Cytoplasmic and Nuclear 0
Survivin 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1505

Références

Keskin, O., Tuncbag, N. & Gursoy, A. Predicting protein-protein interactions from the molecular to the proteome level. Chem. Rev. 116, 4884–4909 (2016).
pubmed: 27074302 doi: 10.1021/acs.chemrev.5b00683
Kubota, R. & Hamachi, I. Protein recognition using synthetic small-molecular binders toward optical protein sensing in vitro and in live cells. Chem. Soc. Rev. 44, 4454–4471 (2015).
pubmed: 25805520 doi: 10.1039/C4CS00381K
Scott, D. E., Bayly, A. R., Abell, C. & Skidmore, J. Small molecules, big targets: drug discovery faces the protein-protein interaction challenge. Nat. Rev. Drug Disco. 15, 533–550 (2016).
doi: 10.1038/nrd.2016.29
van Dun, S., Ottmann, C., Milroy, L. G. & Brunsveld, L. Supramolecular chemistry targeting proteins. J. Am. Chem. Soc. 139, 13960–13968 (2017).
pubmed: 28926241 pmcid: 5639466 doi: 10.1021/jacs.7b01979
McGovern, R. E., Fernandes, H., Khan, A. R., Power, N. P. & Crowley, P. B. Protein camouflage in cytochrome c-calixarene complexes. Nat. Chem. 4, 527–533 (2012).
pubmed: 22717436 doi: 10.1038/nchem.1342
Chinai, J. M. et al. Molecular recognition of insulin by a synthetic receptor. J. Am. Chem. Soc. 133, 8810–8813 (2011).
pubmed: 21473587 pmcid: 3110995 doi: 10.1021/ja201581x
Bier, D. et al. Molecular tweezers modulate 14-3-3 protein-protein interactions. Nat. Chem. 5, 234–239 (2013).
pubmed: 23422566 doi: 10.1038/nchem.1570
Hatai, J. & Schmuck, C. Diverse properties of guanidiniocarbonyl pyrrole-based molecules: artificial analogues of arginine. Acc. Chem. Res. 52, 1709–1720 (2019).
pubmed: 31150198 doi: 10.1021/acs.accounts.9b00142
Bier, D. et al. The molecular tweezer CLR01 stabilizes a disordered protein-protein interface. J. Am. Chem. Soc. 139, 16256–16263 (2017).
pubmed: 29039919 pmcid: 5691318 doi: 10.1021/jacs.7b07939
de Vink, P. J. et al. A binary bivalent supramolecular assembly platform based on cucurbit[8]uril and dimeric adapter protein 14-3-3. Angew. Chem. Int Ed. Engl. 56, 8998–9002 (2017).
pubmed: 28510303 pmcid: 5575475 doi: 10.1002/anie.201701807
Nguyen, H. D., Dang, D. T., van Dongen, J. L. & Brunsveld, L. Protein dimerization induced by supramolecular interactions with cucurbit[8]uril. Angew. Chem. Int Ed. Engl. 49, 895–898 (2010).
pubmed: 20039237 doi: 10.1002/anie.200904413
Trusch, F. et al. Cell entry of a host-targeting protein of oomycetes requires gp96. Nat. Commun. 9, 2347 (2018).
pubmed: 29904064 pmcid: 6002402 doi: 10.1038/s41467-018-04796-3
Vallet, C. et al. Functional disruption of the cancer-relevant interaction between survivin and histone H3 with a guanidiniocarbonyl pyrrole ligand. Angew. Chem. Int Ed. Engl. 59, 5567–5571 (2020).
pubmed: 31916356 pmcid: 7155087 doi: 10.1002/anie.201915400
Mallon, M., Dutt, S., Schrader, T. & Crowley, P. B. Protein camouflage: aupramolecular anion recognition by ubiquitin. ChemBioChem 17, 774–783 (2016).
pubmed: 26818656 doi: 10.1002/cbic.201500477
Smith, L. C., Leach, D. G., Blaylock, B. E., Ali, O. A. & Urbach, A. R. Sequence-specific, nanomolar peptide binding via cucurbit[8]uril-induced folding and inclusion of neighboring side chains. J. Am. Chem. Soc. 137, 3663–3669 (2015).
pubmed: 25710854 doi: 10.1021/jacs.5b00718
McGovern, R. E. et al. Structural study of a small molecule receptor bound to dimethyllysine in lysozyme. Chem. Sci. 6, 442–449 (2015).
pubmed: 25530835 doi: 10.1039/C4SC02383H
Sonzini, S. et al. High affinity recognition of a selected amino acid epitope within a protein by cucurbit[8]uril complexation. Angew. Chem. Int Ed. Engl. 55, 14000–14004 (2016).
pubmed: 27735110 doi: 10.1002/anie.201606763
Ambrosini, G., Adida, C. & Altieri, D. C. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat. Med. 3, 917–921 (1997).
pubmed: 9256286 doi: 10.1038/nm0897-917
Adida, C. et al. Prognostic significance of survivin expression in diffuse large B-cell lymphomas. Blood 96, 1921–1925 (2000).
pubmed: 10961895
Capalbo, G. et al. The role of survivin for radiation therapy. Prognostic and predictive factor and therapeutic target. Strahlenther. Onkol. 183, 593–599 (2007).
pubmed: 17960333 doi: 10.1007/s00066-007-1800-4
Chen, P. et al. Over-expression of survivin and VEGF in small-cell lung cancer may predict the poorer prognosis. Med Oncol. 31, 775 (2014).
pubmed: 24338338 doi: 10.1007/s12032-013-0775-5
Engels, K. et al. Dynamic intracellular survivin in oral squamous cell carcinoma: underlying molecular mechanism and potential as an early prognostic marker. J. Pathol. 211, 532–540 (2007).
pubmed: 17334981 doi: 10.1002/path.2134
Xu, C. et al. High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level. Breast Cancer 21, 482–490 (2014).
pubmed: 22968628 doi: 10.1007/s12282-012-0403-9
Knauer, S. K., Mann, W. & Stauber, R. H. Survivin’s dual role: an export’s view. Cell Cycle 6, 518–521 (2007).
pubmed: 17361097 doi: 10.4161/cc.6.5.3902
Li, F. et al. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 396, 580–584 (1998).
pubmed: 9859993 doi: 10.1038/25141
Knauer, S. K., Bier, C., Habtemichael, N. & Stauber, R. H. The Survivin-Crm1 interaction is essential for chromosomal passenger complex localization and function. EMBO Rep. 7, 1259–1265 (2006).
pubmed: 17099693 pmcid: 1794705 doi: 10.1038/sj.embor.7400824
Knauer, S. K. et al. The survivin isoform survivin-3B is cytoprotective and can function as a chromosomal passenger complex protein. Cell Cycle 6, 1502–1509 (2007).
pubmed: 17582222 doi: 10.4161/cc.6.12.4305
Knauer, S. K. et al. Nuclear export is essential for the tumor-promoting activity of survivin. FASEB J. 21, 207–216 (2007).
pubmed: 17099069 doi: 10.1096/fj.06-5741com
Fokkens, M., Schrader, T. & Klarner, F. G. A molecular tweezer for lysine and arginine. J. Am. Chem. Soc. 127, 14415–14421 (2005).
pubmed: 16218636 doi: 10.1021/ja052806a
Talbiersky, P., Bastkowski, F., Klarner, F. G. & Schrader, T. Molecular clip and tweezer introduce new mechanisms of enzyme inhibition. J. Am. Chem. Soc. 130, 9824–9828 (2008).
pubmed: 18605724 doi: 10.1021/ja801441j
Wilch, C. et al. Molecular tweezers inhibit PARP-1 by a new mechanism. Eur. J. Org. Chem. 2017, 2223–2229 (2017).
doi: 10.1002/ejoc.201601596
Schrader, T., Bitan, G. & Klarner, F. G. Molecular tweezers for lysine and arginine—powerful inhibitors of pathologic protein aggregation. Chem. Commun. (Camb.) 52, 11318–11334 (2016).
doi: 10.1039/C6CC04640A
Vopel, T. et al. Inhibition of huntingtin exon-1 aggregation by the molecular tweezer CLR01. J. Am. Chem. Soc. 139, 5640–5643 (2017).
pubmed: 28406616 pmcid: 5506490 doi: 10.1021/jacs.6b11039
Trusch, F. et al. Molecular tweezers target a protein-protein interface and thereby modulate complex formation. Chem. Commun. (Camb.) 52, 14141–14144 (2016).
doi: 10.1039/C6CC08039A
Engelsma, D., Rodriguez, J. A., Fish, A., Giaccone, G. & Fornerod, M. Homodimerization antagonizes nuclear export of survivin. Traffic 8, 1495–1502 (2007).
pubmed: 17714426 doi: 10.1111/j.1600-0854.2007.00629.x
Pavlyukov, M. S. et al. Survivin monomer plays an essential role in apoptosis regulation. J. Biol. Chem. 286, 23296–23307 (2011).
pubmed: 21536684 pmcid: 3123095 doi: 10.1074/jbc.M111.237586
Heid, C. et al. Molecular tweezers with additional recognition sites. Chemistry 24, 11332–11343 (2018).
pubmed: 30015416 doi: 10.1002/chem.201801508
Sun, C., Nettesheim, D., Liu, Z. & Olejniczak, E. T. Solution structure of human survivin and its binding interface with Smac/Diablo. Biochemistry 44, 11–17 (2005).
pubmed: 15628841 doi: 10.1021/bi0485171
Dutt, S. et al. Molecular tweezers with varying anions: a comparative study. J. Org. Chem. 78, 6721–6734 (2013).
pubmed: 23750919 doi: 10.1021/jo4009673
García-Santisteban, I., et al. A cellular reporter to evaluate CRM1 nuclear export activity: functional analysis of the cancer-related mutant E571K. Cell. Mol. Life Sci. 73, 4685–4699 (2016).
pubmed: 27312238 doi: 10.1007/s00018-016-2292-0
Sowislok A. A. Ein neuer Weg zu asymmetrischen Klammern und Pinzetten mit Phosphoramiditen. Universität Duisburg-Essen (2019).
Li, H., Aneja, R. & Chaiken, I. Click chemistry in peptide-based drug design. Molecules 18, 9797–9817 (2013).
pubmed: 23959192 pmcid: 4155329 doi: 10.3390/molecules18089797
Lallana, E., Riguera, R. & Fernandez‐Megia, E. Reliable and efficient procedures for the conjugation of biomolecules through Huisgen azide–alkyne cycloadditions. Angew. Chem. Int Ed. Engl. 50, 8794–8804 (2011).
pubmed: 21905176 doi: 10.1002/anie.201101019
Keller R. L. The computer aided resonance assignment tutorial. CANTINA Verlag 1st ed. (2004).
Sali, A. & Blundell, T. L. Comparative protein modelling by satisfaction of spatial restraints. J. Mol. Biol. 234, 779–815 (1993).
pubmed: 8254673 doi: 10.1006/jmbi.1993.1626
Chantalat, L. et al. Crystal structure of human survivin reveals a bow tie-shaped dimer with two unusual alpha-helical extensions. Mol. Cell 6, 183–189 (2000).
pubmed: 10949039 doi: 10.1016/S1097-2765(05)00020-1
Verdecia, M. A. et al. Structure of the human anti-apoptotic protein survivin reveals a dimeric arrangement. Nat. Struct. Biol. 7, 602–608 (2000).
pubmed: 10876248 doi: 10.1038/77929
Niedzialkowska, E. et al. Molecular basis for phosphospecific recognition of histone H3 tails by Survivin paralogues at inner centromeres. Mol. Biol. Cell 23, 1457–1466 (2012).
pubmed: 22357620 pmcid: 3327328 doi: 10.1091/mbc.e11-11-0904
Laskowski, R. A., MacArthur, M. W., Moss, D. S. & Thornton, J. M. PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 26, 283–291 (1993).
doi: 10.1107/S0021889892009944
Arnold, K., Bordoli, L., Kopp, J. & Schwede, T. The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling. Bioinformatics 22, 195–201 (2006).
pubmed: 16301204 doi: 10.1093/bioinformatics/bti770
Pronk, S. et al. GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit. Bioinformatics 29, 845–854 (2013).
pubmed: 23407358 pmcid: 3605599 doi: 10.1093/bioinformatics/btt055
Hornak, V. et al. Comparison of multiple Amber force fields and development of improved protein backbone parameters. Proteins 65, 712–725 (2006).
pubmed: 16981200 pmcid: 4805110 doi: 10.1002/prot.21123
Peters, M. B. et al. Structural survey of zinc containing proteins and the development of the Zinc AMBER Force Field (ZAFF). J. Chem. Theory Comput 6, 2935–2947 (2010).
pubmed: 20856692 pmcid: 2941202 doi: 10.1021/ct1002626
Case, D. A. et al. AMBER 12. University of California, San Francisco (2012).
Sousa da Silva, A. W. & Vranken, W. F. ACPYPE - AnteChamber PYthon Parser interfacE. BMC Res Notes 5, 367 (2012).
pubmed: 22824207 pmcid: 3461484 doi: 10.1186/1756-0500-5-367
Berendsen, H. J. C., Grigera, J. R. & Straatsma, T. P. The missing term in effective pair potentials. J. Phys. Chem. 91, 6269–6271 (1987).
doi: 10.1021/j100308a038
Bussi, G., Donadio, D. & Parrinello, M. Canonical sampling through velocity rescaling. J. Chem. Phys. 126, 014101 (2007).
pubmed: 17212484 doi: 10.1063/1.2408420
Parrinello, M. & Rahman, A. Polymorphic transitions in single crystals: a new molecular dynamics method. J. Appl. Phys. 52, 7182–7190 (1981).
doi: 10.1063/1.328693
Páll, S. & Hess, B. A flexible algorithm for calculating pair interactions on SIMD architectures. Computer Phys. Commun. 184, 2641–2650 (2013).
doi: 10.1016/j.cpc.2013.06.003
Darden, T., York, D. & Pedersen, L. Particle mesh Ewald: an N log(N) method for Ewald sums in large systems. J. Chem. Phys. 98, 10089–10092 (1993).
doi: 10.1063/1.464397
Hess, B., Bekker, H., Berendsen, H. J. C. & Fraaije, J. G. E. M. LINCS: a linear constraint solver for molecular simulations. J. Computational Chem. 18, 1463–1472 (1997).
doi: 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H
Kaufman L., Rousseeuw P. J. Clustering by means of medoids. 405–416 (1987).
R Core Team. R: a language and environment for statistical computing. Available at www.R-project.org (2016).
Rousseeuw, P. Silhouettes: a graphical aid to the interpretation and validation of cluster analysis. J. Computational Appl. Math. 20, 53–65 (1987) .
doi: 10.1016/0377-0427(87)90125-7
Phillips, J. C. et al. Scalable molecular dynamics with NAMD. J. Comput Chem. 26, 1781–1802 (2005).
pubmed: 16222654 pmcid: 2486339 doi: 10.1002/jcc.20289
Klauda, J. B. et al. Update of the CHARMM all-atom additive force field for lipids: validation on six lipid types. J. Phys. Chem. B 114, 7830–7843 (2010).
pubmed: 20496934 pmcid: 2922408 doi: 10.1021/jp101759q
Vanommeslaeghe, K. et al. CHARMM general force field: a force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields. J. Comput Chem. 31, 671–690 (2010).
pubmed: 19575467 pmcid: 2888302
Mark, P. & Nilsson, L. Structure and dynamics of the TIP3P, SPC, and SPC/E water models at 298 K. J. Phys. Chem. A 105, 9954–9960 (2001).
doi: 10.1021/jp003020w
Sherwood, P. et al. QUASI: a general purpose implementation of the QM/MM approach and its application to problems in catalysis. J. Mol. Struc-Theochem. 632, 1–28 (2003).
doi: 10.1016/S0166-1280(03)00285-9
Kastner, J. et al. DL-FIND: an open-source geometry optimizer for atomistic simulations. J. Phys. Chem. A 113, 11856–11865 (2009).
pubmed: 19639948 doi: 10.1021/jp9028968
Ahlrichs, R., Bär, M., Häser, M., Horn, H. & Kölmel, C. Electronic structure calculations on workstation computers: the program system turbomole. Chem. Phys. Lett. 162, 165–169 (1989).
doi: 10.1016/0009-2614(89)85118-8
Lin, H. & Truhlar, D. G. QM/MM: what have we learned, where are we, and where do we go from here? Theor. Chem. Acc. 117, 185 (2006).
doi: 10.1007/s00214-006-0143-z
Cisneros, G. A., Piquemal, J. P. & Darden, T. A. Quantum mechanics/molecular mechanics electrostatic embedding with continuous and discrete functions. J. Phys. Chem. B 110, 13682–13684 (2006).
pubmed: 16836309 pmcid: 2656107 doi: 10.1021/jp062768x
Grimme, S. Density functional theory with London dispersion corrections. WIREs Computational Mol. Sci. 1, 211–228 (2011).
doi: 10.1002/wcms.30
Humphrey, W., Dalke, A. & Schulten, K. VMD: Visual molecular dynamics. J. Mol. Graph. 14, 33–38 (1996).
pubmed: 8744570 doi: 10.1016/0263-7855(96)00018-5
Pang, Y. T., Miao, Y., Wang, Y. & McCammon, J. A. Gaussian accelerated molecular dynamics in NAMD. J. Chem. Theory Comput 13, 9–19 (2017).
pubmed: 28034310 doi: 10.1021/acs.jctc.6b00931

Auteurs

Annika Meiners (A)

Department of Molecular Biology II, Centre for Medical Biotechnology (ZMB), University of Duisburg-Essen, Essen, Germany.

Sandra Bäcker (S)

Department of Molecular Biology II, Centre for Medical Biotechnology (ZMB), University of Duisburg-Essen, Essen, Germany.

Inesa Hadrović (I)

Institute of Organic Chemistry I, Faculty of Chemistry, University of Duisburg-Essen, Essen, Germany.

Christian Heid (C)

Institute of Organic Chemistry I, Faculty of Chemistry, University of Duisburg-Essen, Essen, Germany.

Christine Beuck (C)

Department of Structural and Medicinal Biology, Centre for Medical Biotechnology (ZMB), University of Duisburg-Essen, Essen, Germany.

Yasser B Ruiz-Blanco (YB)

Department of Computational Biochemistry, Centre for Medical Biotechnology (ZMB), University of Duisburg-Essen, Essen, Germany.

Joel Mieres-Perez (J)

Department of Computational Biochemistry, Centre for Medical Biotechnology (ZMB), University of Duisburg-Essen, Essen, Germany.

Marius Pörschke (M)

Department of Structural and Medicinal Biology, Centre for Medical Biotechnology (ZMB), University of Duisburg-Essen, Essen, Germany.

Jean-Noël Grad (JN)

Department of Bioinformatics and Computational Biophysics, Centre for Medical Biotechnology (ZMB), University of Duisburg-Essen, Essen, Germany.

Cecilia Vallet (C)

Department of Molecular Biology II, Centre for Medical Biotechnology (ZMB), University of Duisburg-Essen, Essen, Germany.

Daniel Hoffmann (D)

Department of Bioinformatics and Computational Biophysics, Centre for Medical Biotechnology (ZMB), University of Duisburg-Essen, Essen, Germany.

Peter Bayer (P)

Department of Structural and Medicinal Biology, Centre for Medical Biotechnology (ZMB), University of Duisburg-Essen, Essen, Germany.

Elsa Sánchez-García (E)

Department of Computational Biochemistry, Centre for Medical Biotechnology (ZMB), University of Duisburg-Essen, Essen, Germany. elsa.sanchez-garcia@uni-due.de.

Thomas Schrader (T)

Institute of Organic Chemistry I, Faculty of Chemistry, University of Duisburg-Essen, Essen, Germany. thomas.schrader@uni-due.de.

Shirley K Knauer (SK)

Department of Molecular Biology II, Centre for Medical Biotechnology (ZMB), University of Duisburg-Essen, Essen, Germany. shirley.knauer@uni-due.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH